In the early phase of enteroviral infection, 2Apro—by cleaving eIF4G and inhibiting cap-dependent host mRNA translation—triggers the formation of atypical SGs (aSGs), which contain some but not all SG marker proteins. The gene discussed is EIF4G1; the disease is enterovirus infectious disease.